Search Results
Aug 06, 2026, 08:55 ET NYSE Content Update: Hadrian Raises $1.37 Billion for 'Factories of the Future'
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Aug. 6, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE
More news about: New York Stock Exchange
Aug 06, 2026, 08:38 ET Ex-Spotify Team Raises $10M for Malachyte to Bring Behavior Intelligence to Consumer Commerce
personalization infrastructure, Malachyte's Behavior Intelligence technology delivers real-time, adaptive personalization without cookies, logins, or pre-existing customer data. The company is headquartered in New York. Learn more at
More news about: Malachyte
Aug 06, 2026, 08:36 ET CruiseHuddle Launches Live Series Exploring Adult Connections, Consent and Safety at Sea
pretending nobody boards a ship hoping to find romance or adult fun."Key Topics Covered in the Debut Episode:Pre-Embarkation Strategies: Connecting safely before stepping onboard.Dating Apps vs. At-Sea Reality: How cruise connections differ from
More news about: CruiseHuddle
Aug 06, 2026, 08:36 ET ZenoWell Unveils Luna Plus: An AI-Driven Vagus Nerve Ecosystem for Your Personalized Life Model
6, 2026 /PRNewswire/ -- Incubated at Heidelberg University Medical School, ZenoWell—a pioneer in advanced neurotechnology—launched the global pre-order of Luna Plus. The next-generation wearable system integrates non-invasive vagus nerve stimulation (VNS) with continuous biometric tracking to help
More news about: ZenoWell Limited
Aug 06, 2026, 08:30 ET Cystic Fibrosis Screening: Laboratory Perspectives and Best Practices, Upcoming Webinar Hosted by Xtalks
calculation and the interpretation of results in the context of a patient's ethnic background. Special attention will be given to the analytical and pre-analytical variables that influence assay performance, as well as the laboratory's role in ensuring consistent and reproducible results across diverse
More news about: Xtalks
Aug 06, 2026, 08:30 ET Roche expands cyclospora testing portfolio to support U.S. public health response
flexible and cost-effective tests," said Marcus Droege, CEO of TIB MOLBIOL.About the TIB MOLBIOL portfolioTIB MOLBIOL develops pre-designed assays and multiple target panels for research use only with
More news about: ROCHE DIAGNOSTICS CORPORATION
Aug 06, 2026, 08:30 ET MDU Resources Reports Second Quarter 2026 Results; Advances Infrastructure Growth Opportunities
Pipeline Project UpdateThe proposed Bakken East Pipeline Project continues to advance through engineering, environmental review and pre-filing activities. With recently signed precedent agreements, we now have executed agreements with all customers that
More news about: MDU Resources Group, Inc.
Aug 06, 2026, 08:00 ET BestEx Research Launches Pulse AI, the World's First AI-Powered Institutional Trading Analytics Platform
Pulse AI's pre-trade analytics capabilities are live for global futures, with equities pre-trade arriving in October. Institutional trading desks work with enormous amounts of market data, and turning data
More news about: BestEx Research
Aug 06, 2026, 08:00 ET WHITE MOUNTAINS REPORTS SECOND QUARTER RESULTS
revenues of $69 million, pre-tax income of $57 million and adjusted EBITDA of $16 million in the second quarter of 2026 compared to total revenues of $20 million, pre-tax income of $11 million and adjusted EBITDA of $16 million in the second quarter of 2025. Total revenues, pre-tax income and adjusted
More news about: White Mountains Insurance Group, Ltd.
Aug 06, 2026, 08:00 ET ClaimsBridge Announces Strategic Investment from Eir Partners Capital and Acquisition of DialysisPPO, Expanding Its Cost Management Ecosystem
healthcare technology platforms. ClaimsBridge garners both savings and efficiencies, with their AI enhanced Celerity engine that offers a single vendor pre-adjudication claim workflow. Operationally, nothing changes for clients: the same team, processes, and standards of excellence in service remain in place.Alongside
More news about: Claimsbridge
Aug 06, 2026, 08:00 ET Burford Reports 2Q26 and YTD26 Financial Results
for investors and analysts at 9.00am EDT / 2.00pm BST on Thursday, August 6, 2026. For swift access to the conference call at the time of the event, pre-registration is encouraged at
More news about: Burford Capital Limited
Aug 06, 2026, 08:00 ET Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
potential partners are underway, enabling future licensing opportunities.Advanced Novavax's differentiated C. difficile vaccine candidate into pre-IND interactions with the FDA and initiated GMP manufacturing process, supporting potential clinical entry as early as 2027.Second Quarter
More news about: Novavax, Inc.
Aug 06, 2026, 07:55 ET KOPPERS REPORTS SECOND QUARTER 2026 RESULTS
Income tax on adjustments to pre-tax income(43.5)
More news about: KOPPERS HOLDINGS INC.
Aug 06, 2026, 07:30 ET ATI Announces Second Quarter 2026 Results
accounts receivable.Second quarter 2025: $8.7 million includes pre-tax charges consisting of $7.1 million for start-up and transaction-related costs and $1.6 million of losses on the sale of customer accounts receivable. These pre-tax charges were partially offset by credits of $1.3 million due to
More news about: ATI
Aug 06, 2026, 07:30 ET SUNSTONE HOTEL INVESTORS REPORTS RESULTS FOR SECOND QUARTER 2026
costs; the write-off of development costs associated with abandoned projects; property-level restructuring, severance, and management transition costs; pre-opening costs associated with extensive renovation projects; debt resolution costs; lease terminations; property insurance restoration proceeds or uninsured
More news about: Sunstone Hotel Investors, Inc.
Aug 06, 2026, 07:30 ET ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
toll-free dial-in number is 1-800-836-8184 for North America and Canada. It is recommended that you join 10 minutes before the event, though you may pre-register at any time. A live webcast of the call will be available under "Events and Presentations" in the Investors section of the ADC Therapeutics
More news about: ADC Therapeutics SA
Aug 06, 2026, 07:30 ET Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
QTc.Hyperuricemia: Hyperuricemia can occur and was reported in 14% of patients, with 16% of these requiring urate-lowering medication without pre-existing gout or hyperuricemia. 0.3% of patients experienced Grade ≥3. Median time to first onset was 2.1 months (range: 7 days to 35.8 months). Dose
More news about: Nuvation Bio, Inc.
Aug 06, 2026, 07:05 ET REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights
in the Phase IIb/III NAAVIGATE study and approximately $108 million estimated net proceeds from an underwritten public offering of common stock and pre-funded warrants. Pro forma cash, cash equivalents and marketable securities as of June 30, 2026 was approximately $313 million, including the impact
More news about: REGENXBIO Inc.
Aug 06, 2026, 07:00 ET Howmet Aerospace Reports Second Quarter 2026 Results
Pre-tax special items for 2Q26 included Acquisition and acquisition-related costs $22. Pre-tax special items for the six months ended 2Q26 included Restructuring and other credits ($93) and Acquisition
More news about: Howmet Aerospace Inc.
Aug 06, 2026, 07:00 ET Lawton Chiles High School student wins Humane Science Award from National Anti-Vivisection Society
school students from over 60 countries and territories to compete for over $7 million in awards, scholarships and internships and is the world's largest pre-college science competition. NAVS is the only animal advocacy organization invited to present an award at ISEF recognizing exceptional student
More news about: National Anti-Vivisection Society (NAVS)
Aug 06, 2026, 07:00 ET Arbe Announces Second Quarter 2026 Financial Results
Company encourages participants to pre-register for the conference call using the following link:https://dpregister.com/sreg/10210907/1048b9b7c88Participants may pre-register at any time, including
More news about: Arbe
Aug 06, 2026, 07:00 ET Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026
patients 1 – 300) are expected in December 2026 and 2Q 2027, respectively.About Kodiak Sciences Inc.Kodiak Sciences (Nasdaq: KOD) is a pre-commercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics. We are focused
More news about: Kodiak Sciences Inc.
Aug 06, 2026, 07:00 ET Insmed Reports Second-Quarter 2026 Financial Results and Provides Business Update
billion.The Company continues to anticipate submitting an average of one to two INDs per year from its pre-clinical research programs.Insmed continues to anticipate that the totality of its pre-clinical research programs will comprise less than 20% of overall expenditures.The Company plans
More news about: Insmed Incorporated
Aug 06, 2026, 07:00 ET Sharon AI Reports Second Quarter 2026 Results
Proceeds from issuance of pre-funded warrants
More news about: Sharon AI Holdings Inc.
Aug 06, 2026, 07:00 ET Evolent Announces Second Quarter 2026 Results
additional goodwill and intangible asset impairments on our results of operations;our obligations to make material payments to certain of our pre-IPO investors for certain tax benefits we may claim in the future;our obligations to make payments under the tax receivables agreement that
More news about: Evolent Health, Inc.